Cargando…

Shigella conjugate vaccine efficacy trial in controlled human model and potential immune correlates of protection

Detalles Bibliográficos
Autores principales:	Raqib, Rubhana, Venkatesan, Malabi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082079/ https://www.ncbi.nlm.nih.gov/pubmed/33873142 http://dx.doi.org/10.1016/j.ebiom.2021.103343

Ejemplares similares

Functional Antibodies and Innate Immune Responses to WRSS1, a Live Oral Shigella sonnei Vaccine Candidate, in Bangladeshi Adults and Children
por: Sarker, Protim, et al.
Publicado: (2021)

Differential Host Immune Responses to Epidemic and Endemic Strains of Shigella dysenteriae Type 1
por: Sayem, Mohammad Abu, et al.
Publicado: (2011)

Evaluation of an intragastric challenge model for Shigella dysenteriae 1 in rhesus monkeys (Macaca mulatta) for the pre-clinical assessment of Shigella vaccine formulations
por: Islam, Dilara, et al.
Publicado: (2014)

Clinical Trial of an Oral Live Shigella sonnei Vaccine Candidate, WRSS1, in Thai Adults
por: Pitisuttithum, Punnee, et al.
Publicado: (2016)

Antibody in Lymphocyte Supernatant (ALS) responses after oral vaccination with live Shigella sonnei vaccine candidates WRSs2 and WRSs3 and correlation with serum antibodies, ASCs, fecal IgA and shedding
por: Venkatesan, Malabi M., et al.
Publicado: (2021)

The Galleria mellonella larvae as an in vivo model for evaluation of Shigella virulence
por: Barnoy, Shoshana, et al.
Publicado: (2017)

What Drives the Value of a Shigella Vaccine?
por: Hausdorff, William P., et al.
Publicado: (2022)

Phenylbutyrate Counteracts Shigella Mediated Downregulation of Cathelicidin in Rabbit Lung and Intestinal Epithelia: A Potential Therapeutic Strategy
por: Sarker, Protim, et al.
Publicado: (2011)

Immune Response Characterization after Controlled Infection with Lyophilized Shigella sonnei 53G
por: Clarkson, Kristen A., et al.
Publicado: (2020)

The genome of Shigella dysenteriae strain Sd1617 comparison to representative strains in evaluating pathogenesis
por: Vongsawan, Ajchara A., et al.
Publicado: (2015)

Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protection
por: Talaat, Kawsar R., et al.
Publicado: (2021)

The effect of postpartum vitamin A supplementation on breast milk immune regulators and infant immune functions: study protocol of a randomized, controlled trial
por: Ahmad, Shaikh Meshbahuddin, et al.
Publicado: (2015)

B lymphocytes undergo TLR2-dependent apoptosis upon Shigella infection
por: Nothelfer, Katharina, et al.
Publicado: (2014)

Pivotal Shigella Vaccine Efficacy Trials—Study Design Considerations from a Shigella Vaccine Trial Design Working Group
por: Pavlinac, Patricia B., et al.
Publicado: (2022)

A Novel Shigella O-Polysaccharide–IpaB Conjugate Vaccine Elicits Robust Antibody Responses and Confers Protection against Multiple Shigella Serotypes
por: Desalegn, Girmay, et al.
Publicado: (2023)

Threshold protective levels of serum IgG to Shigella lipopolysaccharide: re-analysis of Shigella vaccine trials data
por: Cohen, Dani, et al.
Publicado: (2023)

Combination vaccines against diarrheal diseases
por: Venkatesan, Malabi M, et al.
Publicado: (2015)

Role of antigen specific T and B cells in systemic and mucosal immune responses in ETEC and Shigella infections, and their potential to serve as correlates of protection in vaccine development
por: Mani, Sachin, et al.
Publicado: (2019)

Discrimination of Escherichia coli, Shigella flexneri, and Shigella sonnei using lipid profiling by MALDI‐TOF mass spectrometry paired with machine learning
por: Pizzato, Jade, et al.
Publicado: (2022)

Shigella Isolates From the Global Enteric Multicenter Study Inform Vaccine Development
por: Livio, Sofie, et al.
Publicado: (2014)

Establishment of a Controlled Human Infection Model with a Lyophilized Strain of Shigella sonnei 53G
por: Frenck, Robert W., et al.
Publicado: (2020)

The hunt for protective correlates of immunity to Plasmodium falciparum malaria
por: Moormann, Ann M, et al.
Publicado: (2014)

The First-in-Human Synthetic Glycan-Based Conjugate Vaccine Candidate against Shigella
por: van der Put, Robert M. F., et al.
Publicado: (2022)

Development of Shigella conjugate vaccines targeting Shigella flexneri 2a and S. flexneri 3a using a simple platform-approach conjugation by squaric acid chemistry
por: Kelly, Meagan, et al.
Publicado: (2023)

Changing Emergence of Shigella Sero-Groups in Bangladesh: Observation from Four Different Diarrheal Disease Hospitals
por: Das, Sumon Kumar, et al.
Publicado: (2013)

Systems approach to define humoral correlates of immunity to Shigella
por: Bernshtein, Biana, et al.
Publicado: (2022)

Exploiting the Redundancy in the Immune System: Vaccines Can Mediate Protection by Eliciting ‘Unnatural’ Immunity
por: Casadevall, Arturo, et al.
Publicado: (2003)

Safety and Immunogenicity of Pneumococcal Conjugate Vaccines in a High-risk Population: A Randomized Controlled Trial of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccine in Papua New Guinean Infants
por: Pomat, William S, et al.
Publicado: (2019)

A high-selenium lentil dietary intervention in Bangladesh to counteract arsenic toxicity: study protocol for a randomized controlled trial
por: Krohn, Regina M., et al.
Publicado: (2016)

Correlation between COVID-19 case fatality rate and percentage of BCG vaccination: is it true the vaccine is protective?
por: Mohamed Hussein, Aliae A. R., et al.
Publicado: (2020)

Surveillance of the impact of pneumococcal conjugate vaccines in developing countries
por: Rodgers, Gail L, et al.
Publicado: (2015)

Host Directed Therapy Against Infection by Boosting Innate Immunity
por: Bergman, Peter, et al.
Publicado: (2020)

The Shigella Vaccines Pipeline
por: MacLennan, Calman Alexander, et al.
Publicado: (2022)

Efficacy of sodium butyrate adjunct therapy in shigellosis: a randomized, double-blind, placebo-controlled clinical trial
por: Raqib, Rubhana, et al.
Publicado: (2012)

Randomized placebo-controlled trial of high-dose prenatal third-trimester vitamin D3 supplementation in Bangladesh: the AViDD trial
por: Roth, Daniel E, et al.
Publicado: (2013)

Editorial Commentary: Fifteen Years of Protection by Meningococcal C Conjugate Vaccines: Lessons From Disease Surveillance
por: Maiden, Martin C. J., et al.
Publicado: (2014)

Importance of neutralization sieve analyses when seeking correlates of HIV-1 vaccine efficacy
por: Montefiori, David C
Publicado: (2014)

Pneumococcal vaccination in persons living with HIV: Pneumococcal conjugate, polysaccharide or both?
por: Dhingra, Bhavna, et al.
Publicado: (2020)

Advances in Polatuzumab Vedotin-PIIQ Therapy: A Review of Treatment Efficacy in Diffuse Large B Cell Lymphoma and High-Grade B Cell Lymphoma
por: Abdur Raqib, Moosa, et al.
Publicado: (2023)

Functional antibodies as immunological endpoints to evaluate protective immunity against Shigella
por: Ndungo, Esther, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_87i63jvkb32rf21ijmi5cb3hkn